Brilliant Medicine innovation Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
1. Pet Malignant Tumor Novel Drug Development Platform: Dedicated to the development of therapeutic drugs targeting life-threatening malignant tumors in pets, utilizing the platform to develop cross-species, broad-spectrum treatments for malignant tumors.
2. Enhanced Pet Health Supplements: Developed to target specific pet physiological functions and physical health. Applying drug development principles, these supplements utilize small-molecule ingredients to reinforce pet health, such as for joints, vision, coat, and more.
2. Enhanced Pet Health Supplements: Developed to target specific pet physiological functions and physical health. Applying drug development principles, these supplements utilize small-molecule ingredients to reinforce pet health, such as for joints, vision, coat, and more.
The content above was translated by Ai
Founded Year
2022
Unified Business No.
90315543
Status
Active
Number of Employees
0
Total Paid-in
Capital
3,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Brilliant Medicine innovation Co., Ltd. focuses on developing novel drugs for the treatment of broad-spectrum and refractory pet malignant tumors, as well as pet health-enhancing foods. Brilliant Medicine innovation Co., Ltd. collaborates with multiple universities and medical research departments, integrating cutting-edge scientific technologies across multiple fields to target continuously activated oncoproteins within the metabolic pathways of malignant tumors for drug therapy.
The content above was translated by Ai
